How McCrory probe derailed a program to help Hartford businesses

The program was to help minority-owned businesses in Hartford’s north end with training and grants up to $15,000. Then ...
Le Lézard

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...